Shaan Syed Khurshid, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Atrial Fibrillation | 31 | 2023 | 5019 | 3.730 |
Why?
|
Cardiomyopathies | 10 | 2023 | 1912 | 2.470 |
Why?
|
Electrocardiography | 14 | 2024 | 6440 | 2.290 |
Why?
|
Stroke | 13 | 2023 | 9963 | 1.120 |
Why?
|
Ventricular Dysfunction, Left | 3 | 2023 | 2059 | 1.060 |
Why?
|
Pacemaker, Artificial | 2 | 2023 | 817 | 0.920 |
Why?
|
Cardiac Pacing, Artificial | 4 | 2023 | 846 | 0.920 |
Why?
|
Artificial Intelligence | 4 | 2023 | 2187 | 0.790 |
Why?
|
Heart Ventricles | 5 | 2023 | 3801 | 0.740 |
Why?
|
Brugada Syndrome | 1 | 2021 | 97 | 0.730 |
Why?
|
Atrial Flutter | 1 | 2022 | 264 | 0.710 |
Why?
|
Models, Cardiovascular | 2 | 2022 | 994 | 0.690 |
Why?
|
Electrocardiography, Ambulatory | 2 | 2022 | 585 | 0.670 |
Why?
|
Heart Conduction System | 3 | 2023 | 1048 | 0.640 |
Why?
|
Electric Countershock | 1 | 2021 | 535 | 0.630 |
Why?
|
Perceptual Disorders | 2 | 2011 | 196 | 0.630 |
Why?
|
Arrhythmias, Cardiac | 2 | 2018 | 2267 | 0.600 |
Why?
|
Cryosurgery | 1 | 2022 | 453 | 0.590 |
Why?
|
Cardiac Resynchronization Therapy Devices | 1 | 2017 | 124 | 0.560 |
Why?
|
Electric Stimulation Therapy | 1 | 2022 | 605 | 0.550 |
Why?
|
Ventricular Function, Left | 7 | 2023 | 3656 | 0.540 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2021 | 859 | 0.530 |
Why?
|
Risk Assessment | 12 | 2023 | 23320 | 0.510 |
Why?
|
Ventricular Function, Right | 3 | 2023 | 592 | 0.510 |
Why?
|
Heart Failure | 9 | 2024 | 10856 | 0.510 |
Why?
|
Phenethylamines | 1 | 2015 | 101 | 0.500 |
Why?
|
Defibrillators, Implantable | 2 | 2021 | 1440 | 0.480 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2017 | 532 | 0.400 |
Why?
|
Incidence | 11 | 2023 | 20928 | 0.400 |
Why?
|
Decision Support Techniques | 1 | 2021 | 1952 | 0.390 |
Why?
|
Models, Genetic | 1 | 2021 | 3493 | 0.390 |
Why?
|
Anticoagulants | 4 | 2020 | 4595 | 0.380 |
Why?
|
Catheter Ablation | 2 | 2022 | 2746 | 0.380 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2015 | 790 | 0.370 |
Why?
|
Reperfusion | 1 | 2011 | 284 | 0.350 |
Why?
|
Exercise | 2 | 2023 | 5611 | 0.350 |
Why?
|
Risk Factors | 17 | 2023 | 72145 | 0.330 |
Why?
|
Mass Screening | 3 | 2022 | 5238 | 0.330 |
Why?
|
Vision, Monocular | 1 | 2009 | 78 | 0.330 |
Why?
|
Bradycardia | 2 | 2022 | 305 | 0.320 |
Why?
|
Middle Aged | 29 | 2024 | 213127 | 0.320 |
Why?
|
Humans | 57 | 2024 | 742088 | 0.310 |
Why?
|
Electronic Health Records | 6 | 2023 | 4440 | 0.300 |
Why?
|
Male | 33 | 2024 | 349538 | 0.280 |
Why?
|
Brain Ischemia | 1 | 2020 | 3258 | 0.270 |
Why?
|
Sulfonamides | 1 | 2015 | 1932 | 0.260 |
Why?
|
Aged | 23 | 2023 | 162944 | 0.260 |
Why?
|
Stroke Volume | 5 | 2023 | 4983 | 0.240 |
Why?
|
Predictive Value of Tests | 6 | 2023 | 15056 | 0.240 |
Why?
|
Algorithms | 4 | 2023 | 13853 | 0.240 |
Why?
|
Female | 29 | 2024 | 379592 | 0.230 |
Why?
|
Genome-Wide Association Study | 7 | 2023 | 12220 | 0.230 |
Why?
|
Cardiovascular Diseases | 3 | 2023 | 15108 | 0.220 |
Why?
|
Arrhythmogenic Right Ventricular Dysplasia | 1 | 2023 | 161 | 0.210 |
Why?
|
Aged, 80 and over | 12 | 2022 | 57683 | 0.200 |
Why?
|
Time Factors | 6 | 2021 | 40054 | 0.200 |
Why?
|
Prostheses and Implants | 1 | 2009 | 1385 | 0.200 |
Why?
|
Aortic Aneurysm | 2 | 2022 | 643 | 0.190 |
Why?
|
Retrospective Studies | 11 | 2023 | 77098 | 0.190 |
Why?
|
Cerebrovascular Circulation | 1 | 2011 | 2732 | 0.190 |
Why?
|
Endophenotypes | 1 | 2022 | 250 | 0.190 |
Why?
|
Cost-Benefit Analysis | 3 | 2022 | 5385 | 0.180 |
Why?
|
Age Factors | 4 | 2021 | 18355 | 0.180 |
Why?
|
Action Potentials | 2 | 2018 | 1814 | 0.180 |
Why?
|
Tricuspid Valve | 1 | 2022 | 400 | 0.170 |
Why?
|
Survival Rate | 4 | 2021 | 12773 | 0.170 |
Why?
|
Cardiomyopathy, Dilated | 2 | 2022 | 851 | 0.160 |
Why?
|
Treatment Outcome | 6 | 2023 | 62966 | 0.160 |
Why?
|
Attention | 1 | 2009 | 2396 | 0.160 |
Why?
|
Asymptomatic Diseases | 1 | 2021 | 552 | 0.160 |
Why?
|
Prevalence | 3 | 2023 | 15194 | 0.160 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2023 | 578 | 0.160 |
Why?
|
Long QT Syndrome | 1 | 2022 | 453 | 0.160 |
Why?
|
Heart | 4 | 2023 | 4462 | 0.150 |
Why?
|
Natural Language Processing | 2 | 2023 | 1035 | 0.150 |
Why?
|
Electronic Prescribing | 1 | 2018 | 121 | 0.150 |
Why?
|
Oxygen Consumption | 1 | 2024 | 1869 | 0.150 |
Why?
|
Follow-Up Studies | 6 | 2021 | 39004 | 0.150 |
Why?
|
Models, Economic | 1 | 2021 | 713 | 0.150 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2023 | 964 | 0.140 |
Why?
|
Exercise Test | 1 | 2024 | 2075 | 0.140 |
Why?
|
Comparative Effectiveness Research | 1 | 2021 | 681 | 0.140 |
Why?
|
Heart Rate | 2 | 2018 | 4091 | 0.140 |
Why?
|
Health Services Misuse | 1 | 2018 | 243 | 0.140 |
Why?
|
Cardiovascular System | 1 | 2023 | 827 | 0.130 |
Why?
|
Intracranial Hemorrhages | 1 | 2021 | 854 | 0.130 |
Why?
|
Biological Specimen Banks | 1 | 2020 | 707 | 0.130 |
Why?
|
Pulse Therapy, Drug | 1 | 2015 | 35 | 0.130 |
Why?
|
Aorta, Thoracic | 1 | 2021 | 1080 | 0.130 |
Why?
|
Echocardiography | 3 | 2022 | 5097 | 0.130 |
Why?
|
Quality-Adjusted Life Years | 1 | 2021 | 1679 | 0.130 |
Why?
|
Equipment Design | 1 | 2023 | 3582 | 0.130 |
Why?
|
Aorta | 1 | 2022 | 2057 | 0.120 |
Why?
|
Cognition Disorders | 1 | 2009 | 4030 | 0.120 |
Why?
|
Fever | 1 | 2022 | 1612 | 0.120 |
Why?
|
Ventricular Remodeling | 1 | 2022 | 1224 | 0.120 |
Why?
|
Prospective Studies | 5 | 2023 | 53187 | 0.120 |
Why?
|
Administration, Oral | 2 | 2018 | 3913 | 0.110 |
Why?
|
Pennsylvania | 1 | 2014 | 613 | 0.110 |
Why?
|
Medical Order Entry Systems | 1 | 2018 | 544 | 0.110 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2023 | 3760 | 0.110 |
Why?
|
Proportional Hazards Models | 3 | 2019 | 12344 | 0.100 |
Why?
|
Primary Health Care | 3 | 2023 | 4551 | 0.100 |
Why?
|
Multivariate Analysis | 2 | 2016 | 12242 | 0.100 |
Why?
|
Equipment Failure | 1 | 2014 | 579 | 0.100 |
Why?
|
Genetic Association Studies | 1 | 2020 | 2699 | 0.100 |
Why?
|
Recovery of Function | 1 | 2021 | 2924 | 0.100 |
Why?
|
Cohort Studies | 4 | 2023 | 40450 | 0.090 |
Why?
|
Hemorrhage | 2 | 2022 | 3461 | 0.090 |
Why?
|
Public Health | 1 | 2023 | 2594 | 0.090 |
Why?
|
Chi-Square Distribution | 1 | 2016 | 3510 | 0.090 |
Why?
|
Recurrence | 3 | 2020 | 8333 | 0.090 |
Why?
|
Eye Protective Devices | 1 | 2009 | 33 | 0.090 |
Why?
|
Adult | 9 | 2024 | 213712 | 0.090 |
Why?
|
Heart Diseases | 1 | 2022 | 2789 | 0.080 |
Why?
|
Spatial Behavior | 1 | 2009 | 90 | 0.080 |
Why?
|
Sensory Deprivation | 1 | 2009 | 109 | 0.080 |
Why?
|
Health Care Costs | 1 | 2021 | 3203 | 0.080 |
Why?
|
Guideline Adherence | 1 | 2018 | 2266 | 0.080 |
Why?
|
Alcohol Drinking | 1 | 2020 | 3957 | 0.080 |
Why?
|
Orientation | 1 | 2009 | 327 | 0.080 |
Why?
|
Neuropsychological Tests | 2 | 2011 | 6974 | 0.070 |
Why?
|
Life Style | 1 | 2018 | 3824 | 0.070 |
Why?
|
Tachycardia, Ventricular | 1 | 2015 | 1272 | 0.070 |
Why?
|
Atherosclerosis | 1 | 2022 | 3428 | 0.070 |
Why?
|
Space Perception | 1 | 2009 | 474 | 0.070 |
Why?
|
Heart Defects, Congenital | 1 | 2022 | 4566 | 0.070 |
Why?
|
Severity of Illness Index | 2 | 2015 | 15530 | 0.060 |
Why?
|
Prognosis | 2 | 2024 | 29010 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2017 | 10943 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2021 | 8925 | 0.060 |
Why?
|
Massachusetts | 1 | 2017 | 8662 | 0.060 |
Why?
|
Disease-Free Survival | 1 | 2015 | 6891 | 0.060 |
Why?
|
Photic Stimulation | 1 | 2011 | 2027 | 0.060 |
Why?
|
Brain | 1 | 2011 | 26343 | 0.060 |
Why?
|
Comorbidity | 1 | 2018 | 10372 | 0.060 |
Why?
|
Odds Ratio | 1 | 2016 | 9846 | 0.060 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7276 | 0.050 |
Why?
|
Coronary Artery Disease | 1 | 2022 | 6454 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 2 | 2023 | 17400 | 0.050 |
Why?
|
Nuclear Localization Signals | 1 | 2022 | 80 | 0.050 |
Why?
|
Adaptation, Physiological | 1 | 2009 | 1310 | 0.050 |
Why?
|
Body Weights and Measures | 1 | 2022 | 211 | 0.050 |
Why?
|
Visual Fields | 1 | 2009 | 1049 | 0.050 |
Why?
|
Functional Laterality | 1 | 2009 | 2290 | 0.050 |
Why?
|
Myocardial Infarction | 1 | 2023 | 11690 | 0.050 |
Why?
|
Logistic Models | 1 | 2016 | 13403 | 0.050 |
Why?
|
Lamin Type A | 1 | 2022 | 190 | 0.050 |
Why?
|
Hospitalization | 1 | 2021 | 10232 | 0.050 |
Why?
|
Registries | 3 | 2023 | 8077 | 0.050 |
Why?
|
Psychomotor Performance | 1 | 2009 | 1895 | 0.050 |
Why?
|
Myocardium | 2 | 2023 | 4775 | 0.050 |
Why?
|
United States | 4 | 2021 | 69693 | 0.040 |
Why?
|
Chronic Disease | 1 | 2015 | 9144 | 0.040 |
Why?
|
Cross-Sectional Studies | 1 | 2020 | 24913 | 0.040 |
Why?
|
Attitude | 1 | 2023 | 772 | 0.040 |
Why?
|
Virulence | 1 | 2022 | 1328 | 0.040 |
Why?
|
Automation | 1 | 2020 | 584 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 2 | 2022 | 35342 | 0.040 |
Why?
|
Fibrosis | 1 | 2023 | 2026 | 0.030 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2022 | 685 | 0.030 |
Why?
|
Age of Onset | 1 | 2022 | 3266 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2022 | 1780 | 0.030 |
Why?
|
Hyperlipidemias | 1 | 2019 | 786 | 0.030 |
Why?
|
Hypothyroidism | 1 | 2019 | 659 | 0.030 |
Why?
|
Phenotype | 2 | 2022 | 16331 | 0.030 |
Why?
|
Body Surface Potential Mapping | 1 | 2015 | 238 | 0.030 |
Why?
|
Quantitative Trait Loci | 1 | 2021 | 2015 | 0.030 |
Why?
|
Learning | 1 | 2023 | 1705 | 0.030 |
Why?
|
Body Height | 1 | 2019 | 1574 | 0.030 |
Why?
|
ROC Curve | 1 | 2020 | 3528 | 0.030 |
Why?
|
Heart Valve Diseases | 1 | 2019 | 1067 | 0.030 |
Why?
|
Peripheral Arterial Disease | 1 | 2019 | 1184 | 0.020 |
Why?
|
Body Weight | 1 | 2019 | 4664 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2022 | 12958 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2022 | 13921 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2023 | 5304 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10392 | 0.020 |
Why?
|
Databases, Factual | 1 | 2020 | 7716 | 0.020 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2019 | 2195 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2023 | 21719 | 0.020 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2018 | 3067 | 0.020 |
Why?
|
Coronary Disease | 1 | 2019 | 6078 | 0.020 |
Why?
|
Body Mass Index | 1 | 2022 | 12695 | 0.020 |
Why?
|
Blood Pressure | 1 | 2019 | 8541 | 0.010 |
Why?
|
Quality Improvement | 1 | 2018 | 3738 | 0.010 |
Why?
|
Smoking | 1 | 2019 | 8969 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2022 | 20086 | 0.010 |
Why?
|
Hypertension | 1 | 2019 | 8455 | 0.010 |
Why?
|